ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 46 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $869,000 | -46.1% | 722,836 | 0.0% | 0.00% | -50.0% |
| Q3 2015 | $1,612,000 | -0.1% | 722,836 | +4.3% | 0.00% | 0.0% |
| Q2 2015 | $1,614,000 | -28.2% | 692,836 | -33.7% | 0.00% | -33.3% |
| Q1 2015 | $2,248,000 | -6.1% | 1,045,672 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $2,394,000 | +71.5% | 1,045,672 | +100.0% | 0.00% | +50.0% |
| Q3 2014 | $1,396,000 | -28.4% | 522,836 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $1,950,000 | -36.2% | 522,836 | +101.2% | 0.00% | -50.0% |
| Q1 2014 | $3,055,000 | +41.0% | 259,800 | 0.0% | 0.00% | +33.3% |
| Q4 2013 | $2,167,000 | -10.0% | 259,800 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $2,408,000 | -5.4% | 259,800 | 0.0% | 0.00% | -25.0% |
| Q2 2013 | $2,546,000 | – | 259,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu KCG Holdings LLC | 86,824 | $31,000 | 0.00% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 46,100 | $17,000 | 0.00% |
| DEUTSCHE BANK AG\ | 1,405 | $0 | 0.00% |
| CITIGROUP INC | 9,751 | $4,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 17,281 | $6,000 | 0.00% |
| MORGAN STANLEY | 4,250 | $2,000 | 0.00% |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM | 48,944 | $18,000 | 0.00% |
| BlackRock Inc. | 927,688 | $334,000 | 0.00% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 6,600 | $2,000 | 0.00% |
| Bank of New York Mellon Corp | 62,846 | $22,000 | 0.00% |